Stay updated with breaking news from Aadi Bioscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Wall Street analysts expect Aadi Bioscience, Inc. (NASDAQ:AADI – Get Rating) to report $510,000.00 in sales for the current quarter, according to Zacks. Two analysts have made estimates for Aadi Bioscience’s earnings, with the lowest sales estimate coming in at $250,000.00 and the highest estimate coming in at $780,000.00. The business is expected to announce […]
Aadi Bioscience (NASDAQ:AADI – Get Rating) had its price target cut by equities research analysts at HC Wainwright from $49.00 to $48.00 in a research note issued on Monday, Benzinga reports. The brokerage currently has a “buy” rating on the stock. HC Wainwright’s target price indicates a potential upside of 174.76% from the company’s previous […]
- First rigorous analysis estimates TSC1 and TSC2 definite impact alteration incidence in U.S. as approximately 12,000 ...
- First rigorous analysis estimates TSC1 and TSC2 definite impact alteration incidence in U.S. as approximately 12,000 advanced cancer patients in 2030 ...
Insider analyzed hundreds of life-science companies to identify the 17 drug developers that are growing the fastest.